Peer-influenced content. Sources you trust. No registration required. This is HCN.
The New England Journal of Medicine
In a phase 3 trial comparing belzutifan to everolimus for advanced renal-cell carcinoma, belzutifan demonstrated a significant improvement in progression-free survival at 18 months (24.0% vs. 8.3%, P=0.002) and objective response rate (21.9% vs. 3.5%, P<0.001).
Nephrology August 26th 2024
Cleveland Clinic Journal of Medicine
Extraosseous calcification in chronic and end-stage kidney disease involves a complex pathogenesis, impacting patient morbidity and mortality through vascular, soft tissue, and calciphylaxis manifestations.
Cardiology August 26th 2024
GoodRx Health
Recent studies indicate that stevia, unlike some artificial sweeteners, does not increase appetite or decrease satiety, potentially aiding in weight management efforts.
Cardiology August 20th 2024
MDLinx
High protein intake can be harmful for people with kidney damage and may contribute to lesser-known health issues related to protein fermentation in the gut.
Cardiology August 15th 2024
Epoch Health
A new study finds that 43% of dark chocolate products tested exceeded California’s Proposition 65 limits for lead, while 35% surpassed limits for cadmium.
Cardiology August 12th 2024
Genetic variants in the vitamin D pathway can lead to idiopathic infantile hypercalcemia, with CYP24A1 mutations being the most common cause.
Endocrinology, Diabetes, Metabolism July 23rd 2024